BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34116327)

  • 1. Halting colorectal cancer metastasis via novel dual nanomolar MMP-9/MAO-A quinoxaline-based inhibitors; design, synthesis, and evaluation.
    Ayoup MS; Abu-Serie MM; Awad LF; Teleb M; Ragab HM; Amer A
    Eur J Med Chem; 2021 Oct; 222():113558. PubMed ID: 34116327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenging the anticolorectal cancer capacity of quinoxaline-based scaffold via triazole ligation unveiled new efficient dual VEGFR-2/MAO-B inhibitors.
    Ayoup MS; Ammar A; Abdel-Hamid H; Amer A; Abu-Serie MM; Nasr SA; Ghareeb DA; Teleb M; Tageldin GN
    Bioorg Chem; 2024 Feb; 143():107102. PubMed ID: 38211551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Battle tactics against MMP-9; discovery of novel non-hydroxamate MMP-9 inhibitors endowed with PI3K/AKT signaling attenuation and caspase 3/7 activation via Ugi bis-amide synthesis.
    Ayoup MS; Fouad MA; Abdel-Hamid H; Ramadan ES; Abu-Serie MM; Noby A; Teleb M
    Eur J Med Chem; 2020 Jan; 186():111875. PubMed ID: 31740054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Halting Tumor Progression via Novel Non-Hydroxamate Triazole-Based Mannich Bases MMP-2/9 Inhibitors; Design, Microwave-Assisted Synthesis, and Biological Evaluation.
    Albelwi FF; Teleb M; Abu-Serie MM; Moaty MNAA; Alsubaie MS; Zakaria MA; El Kilany Y; Aouad MR; Hagar M; Rezki N
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of pyrazolo[1,5-a]quinoxalin-4-ones as novel monoamine oxidase inhibitors.
    Panova VA; Filimonov SI; Chirkova ZV; Kabanova MV; Shetnev AA; Korsakov MK; Petzer A; Petzer JP; Suponitsky KY
    Bioorg Chem; 2021 Mar; 108():104563. PubMed ID: 33376014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indoles and 1-(3-(benzyloxy)benzyl)piperazines: Reversible and selective monoamine oxidase B inhibitors identified by screening an in-house compound library.
    Knez D; Hrast M; Frlan R; Pišlar A; Žakelj S; Kos J; Gobec S
    Bioorg Chem; 2022 Feb; 119():105581. PubMed ID: 34990933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered s-Triazine-Based Dendrimer-Honokiol Conjugates as Targeted MMP-2/9 Inhibitors for Halting Hepatocellular Carcinoma.
    Khalil HH; Osman HA; Teleb M; Darwish AI; Abu-Serie MM; Khattab SN; Haiba NS
    ChemMedChem; 2021 Dec; 16(24):3701-3719. PubMed ID: 34547831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology.
    El Ashry ESH; Awad LF; Teleb M; Ibrahim NA; Abu-Serie MM; Abd Al Moaty MN
    Bioorg Chem; 2020 Mar; 96():103616. PubMed ID: 32032847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.
    Yan XQ; Wang ZC; Li Z; Wang PF; Qiu HY; Chen LW; Lu XY; Lv PC; Zhu HL
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4664-71. PubMed ID: 26346367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of new series of quinoxaline based MAO-inhibitors and docking studies.
    Khattab SN; Hassan SY; Bekhit AA; El Massry AM; Langer V; Amer A
    Eur J Med Chem; 2010 Oct; 45(10):4479-89. PubMed ID: 20708306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors.
    Hassan SY; Khattab SN; Bekhit AA; Amer A
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1753-6. PubMed ID: 16356714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors.
    El-Adl K; El-Helby AA; Sakr H; Elwan A
    Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Evaluation of A New Series of Thiazole Derivatives as Potential Antitumor Agents and MMP Inhibitors.
    Kaplancikli ZA; Altıntop MD; Atli O; Sever B; Baysal M; Temel HE; Demirci F; Ozdemir A
    Anticancer Agents Med Chem; 2017; 17(5):674-681. PubMed ID: 27491937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, in vitro and in silico evaluation of new pyrrole derivatives as monoamine oxidase inhibitors.
    Altintop MD; Sever B; Osmaniye D; Sağlık BN; Özdemir A
    Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800082. PubMed ID: 29963739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring new selective 3-benzylquinoxaline-based MAO-A inhibitors: design, synthesis, biological evaluation and docking studies.
    Khattab SN; Abdel Moneim SA; Bekhit AA; El Massry AM; Hassan SY; El-Faham A; Ali Ahmed HE; Amer A
    Eur J Med Chem; 2015 Mar; 93():308-20. PubMed ID: 25707011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, efficient synthesis, docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducers.
    Abbass EM; Khalil AK; Mohamed MM; Eissa IH; El-Naggar AM
    Bioorg Chem; 2020 Nov; 104():104255. PubMed ID: 32927130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site.
    Tripathi RKP; M Sasi V; Gupta SK; Krishnamurthy S; Ayyannan SR
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):37-57. PubMed ID: 29098902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Activity Relationships of UTX-121 Derivatives for the Development of Novel Matrix Metalloproteinase-2/9 Inhibitors.
    Yamahana H; Komiya Y; Takino T; Endo Y; Yamada H; Asada C; Uto Y
    Chem Pharm Bull (Tokyo); 2021; 69(10):1017-1028. PubMed ID: 34602570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and preliminary bioactivity evaluations of 8-hydroxyquinoline derivatives as matrix metalloproteinase (MMP) inhibitors.
    Chen C; Yang X; Fang H; Hou X
    Eur J Med Chem; 2019 Nov; 181():111563. PubMed ID: 31415980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.